Evidence map›Paper›PMID 35411528›Full record

ArticleJournal of general internal medicine2022

Moving Deprescribing Upstream.

Michelle S Keller, Sarah E Vordenberg, Michael A Steinman

Abstract read
In one paragraph

Article in Journal of general internal medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Deprescribing in primary care.Singapore medical journal · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Michelle S KellerCedars-Sinai Medical Center, Division of General Internal Medicine-Health Services Research, 8687 Melrose Ave, Green Building, Office G-562, Los Angeles, CA, 90048, USA. michelle.keller@cshs.org.ORCID 0000-0002-8157-7586
Sarah E VordenbergDepartment of Clinical Pharmacy, University of Michigan, Ann Arbor, MI, USA.
Michael A SteinmanDivision of Geriatrics, University of California San Francisco, San Francisco, CA, USA.

Funding

VARC CoreP30AG044281 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Louise C. Walter · 2013 to 2026
$19.9M
U.S. Deprescribing Research NetworkR24AG064025 · NIA · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI BOYD, CYNTHIA MELINDA, STEINMAN, MICHAEL A. · 2019 to 2023
$9.9M
Mitigating Benzodiazepine and Sedative Use in the Hospital through Inpatient DeprescribingR01AG058911 · NIA · CEDARS-SINAI MEDICAL CENTER · PI PEVNICK, JOSHUA M · 2018 to 2022
$4.0M
Prescribing cascades in older adults with and without dementiaK24AG049057 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STEINMAN, MICHAEL A. · 2015 to 2025
$1.8M
Developing and Testing a Population Health Approach to Deprescribing and Optimizing Medications in Older AdultsK01AG076865 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Michelle Sophie Keller · 2022 to 2026
$618k
NIA NIH HHS K01 AG076865NIA NIH HHS K24 AG049057NIA NIH HHS P30 AG044281NIA NIH HHS R01 AG058911NIA NIH HHS R24 AG064025
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

DeprescriptionsHumansPolypharmacy

Identifiers

PMID35411528
PMCPMC9485366

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.